Proton nuclear magnetic resonance spectroscopy of serum from patients with colorectal neoplasia

European Journal of Surgical Oncology

Volumn 22, Issue 1, 1996, Pages 78-83

  Fluge, O ^a,b   Gilje, K S ^b   Sletten, E ^b   Kvalheim, O M ^b   Skaarland, E ^a   Halvorsen, J F ^a   Farstad, M ^a   Soreide O ^c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Multivariate; Neoplasm; NMR spectroscopy

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECTUM POLYP; SERUM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029881685     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)91682-0     Document Type: Article

References (30)

1. Fossel ET, Carr JM, McDonagh J. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 1986; 315: 1369-76.
2. Okunieff P, Zietman A, Kahn J, Singer S, Neuringer LJ, Levine RA, Evans FE. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. N Engl J Med 1990; 322: 953-8.
3. Sletten E, Kvalheim OM, Kruse S, Farstad M, Søreide O. Detection of malignant tumours by multivariate analysis of proton magnetic resonance spectra of serum. Eur J Cancer 1990; 26: 615-8.
4. Astler VA, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-52.
5. Wold S, Espensen K, Geladi P. Principal component analysis. Chemometrics Intel Lab Syst 1987; 2: 37-52.
6. Kvalheim OM, Karstang TV. A general-purpose program for multivariate data analysis. Chemometrics Intel Lab Syst 1987; 2: 235-7.
7. 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms. J Neurosurg 1988; 68: 931-7.
8. Høfeler H, Scheulen ME. Monitoring of patients with nonseminomatous testicular cancer by nuclear magnetic resonance spectroscopy of plasma. Eur J Cancer Clin Oncol 1989; 25: 1141-3.
9. Shulman R. NMR - another cancer test disappointment. N Engl J Med 1990; 322: 1002-3.
10. Dowd TL, Kaplan BA, Gupta RK, Aisen P. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. Magn Reson Med 1987; 5: 395-7.
11. Buchtal SD, Hardy MA, Brown TR. Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy. Am J Med 1988; 85: 528-32.
12. Wilding P, Senior MB, Inubushi T, Ludwick ML. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy. Clin Chem 1988; 34: 505-11.
13. 1H NMR of plasma for detecting cancer. The effect of trauma on linewidths. NMR Biomed 1989; 2: 66-9.
14. 1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumours. Magn Reson Med 1989; 9: 35-8.
15. Engan T, Krane J, Klepp O. Kvinnsland S. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. N Engl J Med 1990; 322: 949-53.
16. 1H NMR relaxometry or high-resolution spectroscopy of plasma as a screening test for malignant lung disease. Magn Reson Med 1990; 13: 103-32.
17. Otvos JD, Jeyarajah EJ, Hayes LW, Freedman DS, Janjan NA, Anderson T. Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer. Clin Chem 1991; 37: 369-76.
18. Ono S, Moriyasu F, Nabeshima M, et al. Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease. Cancer 1992; 70: 1638-46.
19. Holmberg L, Jakobsson U, Berglund Å, Adami HO. Failure to detect early breast cancer using in vitro nuclear magnetic resonance spectroscopy of plasma. Br J Cancer 1993; 68: 389-92.
20. Moreno A, Esrich E, Prats M, Benito N, Alonso J, Arus C. Study of the ability of proton nuclear magnetic resonance spectroscopy of human plasma to differentiate between controls and breast cancer patients. Oncology 1993; 50: 110-5.
21. 1H NMR spectra of normal and cancer patients: an oncolipid test? Yale J Biol Med 1991; 64: 63-77.
22. Holmes KT, Mackinnon WB, May GL, Wright LC, Dyne M, Tattersall MHN, Mountford CE. Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer. NMR Biomed 1988; 1: 44-9.
23. Gadeholt G, Kruse S, Halsteinslid L, Sletten E. Proton nuclear magnetic resonance spectroscopy of serum lipoproteins in rabbits with implanted VX-2 carcinoma. Eur J Cancer 1990; 26: 611-5.
24. Kruse S, Kvalheim OM, Gadeholt G, Halsteinslid L, Sletten E. Multivariate analysis of proton NMR spectra of serum from rabbits. Monitoring progressive growth of implanted VX-2 carcinoma. Chemometrics Intel Lab Syst 1991; 11: 191-6.
25. Chmurny GN, Hilton BD, Halverson D, et al. An NMR blood test for cancer: a critical assessment. NMR Biomed 1988; 1: 136-50.
26. Fossel ET, McDonagh J, Albright TE, Albright HL. Detection and monitoring of colon cancer by water-suppressed H-1 NMR spectroscopy of plasma (Abstract). American College of Surgeons, Oct-1990.
27. Herring FG, Philips PS, Pritchard PH. Proton magnetic resonance spectroscopy of plasma from patients with dyslipoproteinemia: identification of factors governing methyl and methylene proton line widths. J Lipid Res 1989; 30: 521-8.
28. Mimps MP, Morrisett JD, Mattioli CA, Gotto AM. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma. N Engl J Med 1989; 320: 1452-7.
29. Stamatiadis AP, St.-Toumanidou M, Vyssoulis GP, Manouras AJ, Apostolidis NS. Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. A multivariate analysis. Cancer 1990; 65: 2055-7.
30. Blay JY, Negrier S, Combaret V, et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992; 52: 3317-22.